Ability Pharmaceuticals - Crunchbase Company Profile & Funding

Q: Who invested in Ability Pharmaceuticals?

Ability Pharmaceuticals has 12 investors including Pioneers Emporion And Inveready.

Q: How much funding has Ability Pharmaceuticals raised to date?

Ability Pharmaceuticals has raised obfuscated.

Overview

Ability Pharmaceuticals

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Ability Pharmaceuticals

CB Rank

47847

Ability Pharmaceuticals is a drug discovery and development company.

Founded

obfuscation

Private

Venture - Series Unknown

Barcelona, Catalonia, Spain

1-10

www.abilitypharma.com

Biotechnology

Health Care

Pharmaceutical

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Corporate Round

OBF

obfuscation

Key People

Carles Domènech: Executive Chairman and Chief Scientific Officer
Vanessa Ruz: Head of Finance
Past Role: Sevibe Cells, Chief Financial Officer

Details

Legal Name

ABILITY PHARMACEUTICALS, SL.

Also Known As

AB Therapeutics

Operating Status

Active

Company Type

For Profit

Founders

Carles Domènech, Jordi Espadaler

About the Company

Ability Pharmaceuticals is a drug discovery and development company based in Barcelona, Spain. It develops human therapeutics targeting cell membranes to treat cancer and other indications with unmet medical needs.

Ability Pharmaceuticals is focused on developing new drugs for the treatment of lung cancer and pancreatic cancer. The company

develops Lipid Analogue Therapeutics, a new drug class that modifies the composition of the cell membrane and displays a capacity to influence the local organization of lipid structures in the cell membrane, inducing the formation of non-lamellar phase structures.

Its development pipeline includes ABTL0812 product in preclinical development; and ABTL1014, a drug candidate in preclinical characterization.

Phone Number

+34 935 86 89 77

Contact Email

contact@abilitypharma.com

Predictions & Insights

Growth Insight

See this Growth Insight

Ability Pharmaceuticals is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Runway Speculation

Products & Services

ABTL0812 (Ibrilatazar)

An oral anticancer drug candidate inducing cytotoxic autophagy selectively in cancer cells, currently in phase 2b clinical trials for pancreatic cancer and previously tested in endometrial and lung cancers.

Research & Development

Ability Pharmaceuticals is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Ability Pharmaceuticals	4	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Ability Pharmaceuticals	4	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Ability Pharmaceuticals	4	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Ability Pharmaceuticals	4	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Ability Pharmaceuticals	4	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Ability Pharmaceuticals	4	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Ability Pharmaceuticals	4	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Ability Pharmaceuticals	4	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Ability Pharmaceuticals	4	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Ability Pharmaceuticals	4	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Pioneers Emporion	—	Venture Round - Ability Pharmaceuticals	—
Pioneers Emporion	—	Venture Round - Ability Pharmaceuticals	—
Pioneers Emporion	—	Venture Round - Ability Pharmaceuticals	—
Pioneers Emporion	—	Venture Round - Ability Pharmaceuticals	—
Pioneers Emporion	—	Venture Round - Ability Pharmaceuticals	—